Invesaro

Stocks Health care INSP

NYSE · Health care

Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems, Inc. brought in $898.7M of revenue over the twelve months to June 30, 2026, up 4.3% from a year earlier. Net income was $135M, a net margin of 15.0%. Operating cash flow minus capital spending left $78.5M of free cash flow in fiscal 2025. At June 30, 2026 it held $127.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 3, 2026.

Price
$70.50
+2.46% on the day · September 25, 2026
52-week range $38.91 to $147.03
Market cap
$2B
Revenue (last 12 months)
$898.7M
+4.3% year on year
Net margin
15.0%
P/E
14.4
on FY2025 diluted EPS

What Inspire Medical Systems, Inc. does

Inspire Medical Systems, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker INSP.

Revenue and profit by year

Revenue
FY18: $50.6M $50.6M FY18FY19: $82.1M $82.1M FY19FY20: $115.4M $115.4M FY20FY21: $233.4M $233.4M FY21FY22: $407.9M $407.9M FY22FY23: $624.8M $624.8M FY23FY24: $802.8M $802.8M FY24FY25: $912M $912M FY25
Net income
FY18: -$21.8M -$21.8M FY18FY19: -$33.2M -$33.2M FY19FY20: -$57.2M -$57.2M FY20FY21: -$42M -$42M FY21FY22: -$44.9M -$44.9M FY22FY23: -$21.2M -$21.2M FY23FY24: $53.5M $53.5M FY24FY25: $145.4M $145.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$912M$51M$145.4M$4.89$78.5M
2024$802.8M$36.1M$53.5M$1.75$91.1M
2023$624.8M-$40.3M-$21.2M-$0.72$1M
2022$407.9M-$47.6M-$44.9M-$1.60$2.5M
2021$233.4M-$39.9M-$42M-$1.54-$24.8M
2020$115.4M-$56.2M-$57.2M-$2.19-$55.5M
Next report expected around October 18, 2026.

Estimated from its filing rhythm: about 76 days after its last report of August 3, 2026, its usual gap. Not a date the company has announced. See the report calendar

Where INSP ranks in Health care

Revenue$912M
#152 of 523 in Health care · Top 29%
Revenue growth+13.6%
#210 of 437 in Health care · Top 48%
Net margin15.9%
#65 of 447 in Health care · Top 14%
Free cash flow margin8.6%
#131 of 408 in Health care · Top 32%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Inspire Medical Systems, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 13, 2026
  2. August 12, 2026
  3. August 3, 2026
    Quarterly report 10-Q · period to June 30, 2026
  4. August 3, 2026
  5. July 31, 2026
  6. July 28, 2026
  7. July 24, 2026
  8. July 22, 2026
  9. July 2, 2026
  10. June 26, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 2, 2026. Insider transactions on SEC

What is INSP worth? A DCF from its reported cash flow

Insider trades

What the people running Inspire Medical Systems, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 31, 2026 Kelly Jason PSee Remarks Received as pay 6,350 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about INSP

What does Inspire Medical Systems, Inc. do?

Inspire Medical Systems, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker INSP.

Is Inspire Medical Systems, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $135M on revenue of $898.7M, a net margin of 15.0%.

How much revenue does Inspire Medical Systems, Inc. make?

Over the twelve months to June 30, 2026 Inspire Medical Systems, Inc. reported revenue of $898.7M. That is 4.3% more than a year earlier.

When did Inspire Medical Systems, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 3, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 2, 2026.

Similar companies

Compare INSP with

Compare INSP with any company

Follow INSP

Get an email when Inspire Medical Systems, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow INSP: get an email when it files

Where the numbers come from

Financial figures are the values Inspire Medical Systems, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.